Sun Pharma Q2 net falls 46.5% on Protonix provision
Nov 08 2012 , Mumbai
The Mumbai-based drugmaker said consolidated net profit fell to Rs 3.2 billion during fiscal second quarter ended September from Rs 5.98 billion a year earlier. Net sales rose 40.2 percent to Rs 26.57 billion.
Analysts had estimated the net profit at Rs 7.68 billion, according to Thomson Reuters I/B/E/S.